Xcout IntelHeartSciences Inc.
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.
Subscribe to see HeartSciences Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
HeartSciences Inc. at a glance
HeartSciences Inc. is a medical devices company headquartered in Southlake, United States. It is publicly listed (HSCS) with a market capitalisation of $17.8M. Xcout tracks 11 named people at HeartSciences Inc., including Andrew Simpson (Chief Executive Officer, President & Chairman of the Board of Directors).
HeartSciences Inc. leadership
- Andrew SimpsonChief Executive Officer, President & Chairman of the Board of Directors
- Danielle WatsonChief Financial Officer & Treasurer
- Aaron PetersonVP Research and Development
- Isabella SchmittVP Clinical and Regulatory Affairs
- Jason DomaskVP of Software Engineering & MyoVista Insights Product Owner
- Andrew SimpsonDirector
5 more named people on record for HeartSciences Inc., with roles, board committees and tenure — see the full roster →
HeartSciences Inc. competitors
A few of HeartSciences Inc.'s closest competitors — see the full list of competitors and alternatives →
Artrya Limited is a medical technology firm that harnesses artificial intelligence (AI) to pinpoint individuals at risk of developing coronary artery disease. The company's key offering is Salix, a cloud-based software application. Salix leverages Artrya's proprietary AI to automate the identification of coronary artery disease through the analysis of coronary computed tomography angiography (CCTA) scans. Founded in 2018, the company is headquartered in West Perth, Australia.
iRhythm Technologies, Inc. is headquartered in San Francisco, United States, and focuses on the provision of ambulatory ECG monitoring products and digital healthcare solutions for cardiac care.
Headquartered in Redwood City, California, Biotricity, Inc. is a medical technology enterprise delivering biometric data monitoring solutions, primarily within the United States. The company's efforts are dedicated to supplying remote monitoring capabilities to the medical, healthcare, and individual consumer markets, encompassing both diagnostic tools and ongoing management support for chronic and lifestyle-related conditions. Among its key offerings are the Bioflux mobile cardiac telemetry solution, an integrated ECG device, alongside specialized ECG analysis software designed to process and synthesize patient heart rhythm data, complemented by various software components.
Vibronix, Inc. is a medical device and technology company headquartered in Indiana, USA, established in 2013. The company develops innovative medical imaging and sensing devices utilizing optical and acoustic sensing alongside machine learning.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Operating as a health technology enterprise, TrivarX Limited specializes in crafting artificial intelligence-driven, scientifically validated instruments designed for the assessment and identification of behavioral health disorders. Its market presence extends across Australia and the United States. The company delivers mental well-being provisions tailored for corporate clients through its enterprise health offerings, concurrently developing solutions for medical service providers. Established in 1987, the entity was formerly known as Medibio Limited until its rebranding as TrivarX Limited in October 2023. Its principal place of business is situated in Mount Lawley, Australia.
Get HeartSciences Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on HeartSciences Inc. in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 6 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access